NOC-110

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Refractory or Unexplained Chronic Cough

Drug Information

Target Indication

Refractory or Unexplained Chronic Cough

Clinical Trial

Last updated: 8/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

IQV

IQVIA HOLDINGS INC.

Related Pipeline

Rheumatoid Arthritis

Moderate Chronic Plaque Psoriasis

Carcinoma, Ovarian Epithelial

Arthritis, Rheumatoid

Fabry Disease

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts